Countries could ignore patents for coronavirus treatments, vaccines if unavailable internationally


While the leaders of several countries have called for a global, egalitarian approach to distributing a potential coronavirus vaccine or treatment, there's some concern that certain governments, including those in Washington, Beijing, and New Delhi, are intent on prioritizing domestic use, NBC News reports.
The U.S. Health and Human Services Department expressed such a sentiment in a March statement, while an op-ed in China's state-run newspaper The Global Times said "China has to be by itself in this crucial field." Billionaire Cyrus Poonawalla, the owner of the Serum Institute of India — the world's largest vaccine producer by volume — has said the majority of a coronavirus vaccine "would have to go to our countrymen before it goes abroad."
There's probably not a lot other countries can do about it, per NBC News. But Søren Holm, a professor of bioethics at the University of Manchester, said governments might be willing to take some desperate measures to produce treatments or a vaccine if the country is on the brink of collapse. One possibility is ignoring patents covering drugs and to begin manufacturing them without consent. South Africa made that choice with HIV/AIDS medicine in the 1990s, and drug companies eventually licensed the medication at a lower price. "It showed that these type of threats tend to work," Holm said. Read more at NBC News.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Storm warning
Feature The U.S. is headed for an intense hurricane season. Will a shrunken FEMA and NOAA be able to respond?
-
U.S. v. Skrmetti: Did the trans rights movement overreach?
Feature The Supreme Court upholds a Tennessee law that bans transgender care for minors, dealing a blow to trans rights
-
How would the Trump administration denaturalize immigrant citizens?
Today's Big Question Using civil courts lowers the burden of proof
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia